RESEARCHER PROFILE

Cristoforo Comi

← Back to Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

C

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

Multiple Sclerosis Research StudiesParkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchPeripheral Neuropathies and DisordersNeuroinflammation and Neurodegeneration Mechanisms

Cristoforo Comi works in Multiple Sclerosis Research Studies, Parkinson's Disease Mechanisms and Treatments, Dementia and Cognitive Impairment Research, Peripheral Neuropathies and Disorders, Neuroinflammation and Neurodegeneration Mechanisms. Recorded institutional associations include Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Ospedaliero Universitaria Maggiore della Carita.

260Publications
7,766Citations
46H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

    2021 · 535 citations
  2. Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients

    2018 · 278 citations
  3. Intensive Rehabilitation Treatment in Early Parkinson’s Disease

    2014 · 184 citations
  4. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis

    2011 · 176 citations
  5. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

    2018 · 170 citations
  6. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

    2009 · 158 citations
  7. Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases

    2016 · 156 citations
  8. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis

    2014 · 155 citations
  9. Intensive Rehabilitation Increases BDNF Serum Levels in Parkinsonian Patients

    2013 · 153 citations
  10. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy

    2009 · 149 citations
  11. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence

    2019 · 144 citations
  12. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study

    2018 · 143 citations
  13. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients

    2020 · 139 citations
  14. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature

    2010 · 126 citations
  15. Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline

    2010 · 123 citations
  16. Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease

    2019 · 119 citations
  17. Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients

    2011 · 116 citations
  18. Defective T cell Fas function in patients with multiple sclerosis

    2000 · 113 citations
  19. Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease

    2016 · 104 citations
  20. Immunity and inflammation in neurodegenerative diseases.

    2013 · 100 citations
  21. Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy

    2018 · 97 citations
  22. Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies

    2014 · 89 citations
  23. Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens

    2013 · 89 citations
  24. Oxidative Stress in Non-Alcoholic Fatty Liver Disease

    2022 · 89 citations
  25. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration

    2019 · 88 citations

← Return to the university profile